Belgium· BE-AMP-SAM270435-00

Boostrix Polio

A diphtherie-pertussis-poliomyelitis-tetanus product containing poliovirus type 1 (inactivated), registered in Belgium by GlaxoSmithKline Biologicals. The same ATC class is registered in 11 of our 19 countries.

ATC J07CA02

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about poliovirus type 1 (inactivated)Answers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Diphtherie-pertussis-poliomyelitis-tetanus is registered in 11 of 19 countries.

Countries holding a registration under ATC J07CA02 (diphtherie-pertussis-poliomyelitis-tetanus), each read from that country’s own register.

This record: Belgium, from FAMHP / AFMPS (Belgium)
7 of them publish a price we can compare per daily dose

Search diphtherie-pertussis-poliomyelitis-tetanus products by name

Diphtherie-pertussis-poliomyelitis-tetanus · ATC J07CA02

11 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Switzerlandprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Poliovirus Type 1 (inactivated)
Manufacturer: GlaxoSmithKline Biologicals
Country: Belgium (BE)
ATC code: J07CA02
ATC class: Diphtherie-Pertussis-Poliomyelitis-Tetanus
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 1

be_apb
2374429

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07CA02

Diphtherie-pertussis-poliomyelitis-tetanus, as other registers publish it.

All diphtherie-pertussis-poliomyelitis-tetanus products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/ffcc1a23-f4ef-493b-bb5a-fea32e382f7d
GET /v1/drugs/ffcc1a23-f4ef-493b-bb5a-fea32e382f7d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Suspension for injection in pre-filled syringe",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Boostrix Polio",
  "name_fr": "Boostrix Polio",
  "name_nl": "Boostrix Polio",
  "amp_code": "SAM270435-00",
  "strengths": [
    "40.0000",
    "8.0000",
    "2.0000",
    "8.0000",
    "2.5000",
    "8.0000",
    "20.0000",
    "32.0000"
  ],
  "pack_count": 2,
  "substances": [
    "Poliovirus Type 1 (inactivated)",
    "Bordetella Pertussis Toxoid (PT)",
    "Diphtheria Toxoid (DT)",
    "Bordetella Pertussis Filamentous Hemagglutinin (FHA)",
    "Pertactin (Bordetella Pertussis Antigen)",
    "Poliovirus Type 2 (inactivated)",
    "Tetanus Toxoid",
    "Poliovirus Type 3 (inactivated)",
    "Sodium Chloride"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Diphtheria-Pertussis-Poliomyelitis-Tetanus",
  "authorisation_numbers": [
    "BE270435"
  ]
}

API reference MCP server Plans

See everything about diphtherie-pertussis-poliomyelitis-tetanus.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console